S-methylisothiourea sulfate and aminoguanidine, selective iNOS blockers, have been investigated in type II diabetes-induced neuropathic pain in Wistar strain rats and were shown to decrease pain through inhibition of iNOS and consequently attenuating mechanisms of NO-dependent neurodegeneration [95,102]. The gene discussed is NOS2; the disease is type 2 diabetes mellitus.